Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.32794904 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.32794904 |
3 | aromatic amino acid family catabolic process (GO:0009074) | 6.02041882 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.80305659 |
5 | L-phenylalanine metabolic process (GO:0006558) | 5.80305659 |
6 | indole-containing compound catabolic process (GO:0042436) | 5.68330386 |
7 | indolalkylamine catabolic process (GO:0046218) | 5.68330386 |
8 | tryptophan catabolic process (GO:0006569) | 5.68330386 |
9 | tryptophan metabolic process (GO:0006568) | 5.33988788 |
10 | bile acid biosynthetic process (GO:0006699) | 5.16038281 |
11 | kynurenine metabolic process (GO:0070189) | 5.15611937 |
12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.09552513 |
13 | urea metabolic process (GO:0019627) | 4.92276647 |
14 | urea cycle (GO:0000050) | 4.92276647 |
15 | high-density lipoprotein particle remodeling (GO:0034375) | 4.80986942 |
16 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.72149195 |
17 | nitrogen cycle metabolic process (GO:0071941) | 4.48913368 |
18 | complement activation, alternative pathway (GO:0006957) | 4.48381500 |
19 | homocysteine metabolic process (GO:0050667) | 4.47048361 |
20 | glyoxylate metabolic process (GO:0046487) | 4.42969180 |
21 | bile acid metabolic process (GO:0008206) | 4.35169118 |
22 | regulation of protein activation cascade (GO:2000257) | 4.33275330 |
23 | regulation of fibrinolysis (GO:0051917) | 4.29633648 |
24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.25027973 |
25 | protein carboxylation (GO:0018214) | 4.25027973 |
26 | cellular biogenic amine catabolic process (GO:0042402) | 4.23099037 |
27 | amine catabolic process (GO:0009310) | 4.23099037 |
28 | aromatic amino acid family metabolic process (GO:0009072) | 4.22050899 |
29 | tyrosine metabolic process (GO:0006570) | 4.19416609 |
30 | presynaptic membrane assembly (GO:0097105) | 4.17741789 |
31 | cysteine metabolic process (GO:0006534) | 4.14563514 |
32 | negative regulation of fibrinolysis (GO:0051918) | 4.10954288 |
33 | reverse cholesterol transport (GO:0043691) | 4.10357447 |
34 | indolalkylamine metabolic process (GO:0006586) | 4.06208708 |
35 | alpha-linolenic acid metabolic process (GO:0036109) | 4.05751073 |
36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.03612950 |
37 | protein-lipid complex remodeling (GO:0034368) | 4.03612950 |
38 | macromolecular complex remodeling (GO:0034367) | 4.03612950 |
39 | regulation of complement activation (GO:0030449) | 4.02362727 |
40 | serine family amino acid catabolic process (GO:0009071) | 4.00826112 |
41 | alpha-amino acid catabolic process (GO:1901606) | 3.98053237 |
42 | sulfur amino acid catabolic process (GO:0000098) | 3.92775048 |
43 | triglyceride homeostasis (GO:0070328) | 3.91026754 |
44 | acylglycerol homeostasis (GO:0055090) | 3.91026754 |
45 | glutamate metabolic process (GO:0006536) | 3.90787163 |
46 | coenzyme catabolic process (GO:0009109) | 3.89512298 |
47 | cellular glucuronidation (GO:0052695) | 3.88581999 |
48 | amino-acid betaine metabolic process (GO:0006577) | 3.78009014 |
49 | negative regulation of lipase activity (GO:0060192) | 3.75568336 |
50 | presynaptic membrane organization (GO:0097090) | 3.71292448 |
51 | epoxygenase P450 pathway (GO:0019373) | 3.70094692 |
52 | regulation of triglyceride catabolic process (GO:0010896) | 3.68071681 |
53 | regulation of cholesterol esterification (GO:0010872) | 3.66174661 |
54 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.66101942 |
55 | bile acid and bile salt transport (GO:0015721) | 3.65860992 |
56 | regulation of bile acid biosynthetic process (GO:0070857) | 3.64633068 |
57 | cholesterol efflux (GO:0033344) | 3.64071456 |
58 | low-density lipoprotein particle remodeling (GO:0034374) | 3.62584347 |
59 | phospholipid efflux (GO:0033700) | 3.62342438 |
60 | drug catabolic process (GO:0042737) | 3.61633675 |
61 | exogenous drug catabolic process (GO:0042738) | 3.57449667 |
62 | negative regulation of sterol transport (GO:0032372) | 3.57017128 |
63 | negative regulation of cholesterol transport (GO:0032375) | 3.57017128 |
64 | imidazole-containing compound metabolic process (GO:0052803) | 3.54194379 |
65 | cellular amino acid catabolic process (GO:0009063) | 3.53755022 |
66 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.51938947 |
67 | nucleobase catabolic process (GO:0046113) | 3.51869364 |
68 | plasma lipoprotein particle clearance (GO:0034381) | 3.51290025 |
69 | cellular ketone body metabolic process (GO:0046950) | 3.51266356 |
70 | postsynaptic membrane organization (GO:0001941) | 3.51031414 |
71 | axonal fasciculation (GO:0007413) | 3.44621033 |
72 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.43102712 |
73 | indole-containing compound metabolic process (GO:0042430) | 3.38079939 |
74 | glucuronate metabolic process (GO:0019585) | 3.36504637 |
75 | uronic acid metabolic process (GO:0006063) | 3.36504637 |
76 | blood coagulation, intrinsic pathway (GO:0007597) | 3.27562329 |
77 | retinal ganglion cell axon guidance (GO:0031290) | 3.27028294 |
78 | arginine metabolic process (GO:0006525) | 3.26180217 |
79 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.21641964 |
80 | flavonoid metabolic process (GO:0009812) | 3.20594893 |
81 | neuronal action potential propagation (GO:0019227) | 3.19622520 |
82 | NAD biosynthetic process (GO:0009435) | 3.18468330 |
83 | neuron cell-cell adhesion (GO:0007158) | 3.16522649 |
84 | benzene-containing compound metabolic process (GO:0042537) | 3.16243969 |
85 | cytolysis (GO:0019835) | 3.16115050 |
86 | opsonization (GO:0008228) | 3.15375491 |
87 | cellular modified amino acid catabolic process (GO:0042219) | 3.15099538 |
88 | short-chain fatty acid metabolic process (GO:0046459) | 3.11925427 |
89 | protein activation cascade (GO:0072376) | 3.10034007 |
90 | plasma lipoprotein particle assembly (GO:0034377) | 3.10028148 |
91 | negative regulation of protein activation cascade (GO:2000258) | 3.07313826 |
92 | omega-hydroxylase P450 pathway (GO:0097267) | 3.05853952 |
93 | lysine catabolic process (GO:0006554) | 3.04805123 |
94 | lysine metabolic process (GO:0006553) | 3.04805123 |
95 | neuron recognition (GO:0008038) | 3.03660795 |
96 | fibrinolysis (GO:0042730) | 3.03387024 |
97 | plasma lipoprotein particle organization (GO:0071827) | 3.02873375 |
98 | gamma-aminobutyric acid transport (GO:0015812) | 3.01902255 |
99 | complement activation, classical pathway (GO:0006958) | 3.01073356 |
100 | complement activation (GO:0006956) | 2.99530484 |
101 | ketone body metabolic process (GO:1902224) | 2.98693813 |
102 | positive regulation of lipid catabolic process (GO:0050996) | 2.98073989 |
103 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.97665726 |
104 | cofactor catabolic process (GO:0051187) | 2.96192388 |
105 | carboxylic acid catabolic process (GO:0046395) | 2.96172561 |
106 | organic acid catabolic process (GO:0016054) | 2.96172561 |
107 | intraciliary transport (GO:0042073) | 2.96078292 |
108 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.95524284 |
109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.95524284 |
110 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.95020835 |
111 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.94932485 |
112 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.93621573 |
113 | phospholipid homeostasis (GO:0055091) | 2.92818778 |
114 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.91006451 |
115 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.88155825 |
116 | cerebral cortex cell migration (GO:0021795) | 2.73779516 |
117 | nonmotile primary cilium assembly (GO:0035058) | 2.70355401 |
118 | vocalization behavior (GO:0071625) | 2.69832359 |
119 | regulation of respiratory system process (GO:0044065) | 2.68711067 |
120 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.67237537 |
121 | limb bud formation (GO:0060174) | 2.65893689 |
122 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.65158138 |
123 | olfactory bulb development (GO:0021772) | 2.63997584 |
124 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.63298386 |
125 | protein localization to synapse (GO:0035418) | 2.61267635 |
126 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.59161211 |
127 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.57325146 |
128 | synapse assembly (GO:0007416) | 2.54911148 |
129 | auditory behavior (GO:0031223) | 2.54505405 |
130 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.53926034 |
131 | dendrite morphogenesis (GO:0048813) | 2.53715260 |
132 | limb development (GO:0060173) | 2.51093406 |
133 | appendage development (GO:0048736) | 2.51093406 |
134 | protein localization to cilium (GO:0061512) | 2.46152900 |
135 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.45760555 |
136 | glycosphingolipid biosynthetic process (GO:0006688) | 2.42818768 |
137 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.40983285 |
138 | dendritic spine morphogenesis (GO:0060997) | 2.40644194 |
139 | somite development (GO:0061053) | 2.39407042 |
140 | negative regulation of axon guidance (GO:1902668) | 2.38699919 |
141 | central nervous system neuron axonogenesis (GO:0021955) | 2.36385777 |
142 | regulation of phospholipase A2 activity (GO:0032429) | 2.36203869 |
143 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.35304121 |
144 | cilium assembly (GO:0042384) | 2.34408476 |
145 | cilium morphogenesis (GO:0060271) | 2.32891809 |
146 | magnesium ion transport (GO:0015693) | 2.32494763 |
147 | atrial cardiac muscle cell action potential (GO:0086014) | 2.32489222 |
148 | cilium organization (GO:0044782) | 2.31921642 |
149 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.31205248 |
150 | hippocampus development (GO:0021766) | 2.27572621 |
151 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.26534008 |
152 | protein prenylation (GO:0018342) | 2.26457055 |
153 | prenylation (GO:0097354) | 2.26457055 |
154 | glutamate receptor signaling pathway (GO:0007215) | 2.26446852 |
155 | behavioral response to nicotine (GO:0035095) | 2.26414019 |
156 | regulation of axon guidance (GO:1902667) | 2.26030750 |
157 | forebrain neuron differentiation (GO:0021879) | 2.25834342 |
158 | inner ear receptor stereocilium organization (GO:0060122) | 2.24458846 |
159 | C4-dicarboxylate transport (GO:0015740) | 2.24282331 |
160 | inner ear receptor cell development (GO:0060119) | 2.23532303 |
161 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.23172970 |
162 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.22883047 |
163 | axon extension involved in axon guidance (GO:0048846) | 2.22883047 |
164 | regulation of respiratory gaseous exchange (GO:0043576) | 2.21319312 |
165 | axon extension (GO:0048675) | 2.21176566 |
166 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.17196550 |
167 | membrane depolarization during action potential (GO:0086010) | 2.16477025 |
168 | regulation of synapse assembly (GO:0051963) | 2.16328591 |
169 | establishment of nucleus localization (GO:0040023) | 2.16281754 |
170 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.16040186 |
171 | synaptic transmission, glutamatergic (GO:0035249) | 2.15950071 |
172 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.15322792 |
173 | mechanosensory behavior (GO:0007638) | 2.15035755 |
174 | behavioral response to ethanol (GO:0048149) | 2.15007290 |
175 | innervation (GO:0060384) | 2.14287512 |
176 | ganglion development (GO:0061548) | 2.14260517 |
177 | positive regulation of synapse assembly (GO:0051965) | 2.14171544 |
178 | cochlea development (GO:0090102) | 2.14117804 |
179 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.14049968 |
180 | microtubule anchoring (GO:0034453) | 2.13975532 |
181 | epithelial cilium movement (GO:0003351) | 2.13105290 |
182 | neuron fate determination (GO:0048664) | 2.12113330 |
183 | positive regulation of mitochondrial fission (GO:0090141) | 2.12012151 |
184 | neuron migration (GO:0001764) | 2.10936691 |
185 | smoothened signaling pathway (GO:0007224) | 2.09993497 |
186 | proline transport (GO:0015824) | 2.09670663 |
187 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.09618980 |
188 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.09554207 |
189 | synapse organization (GO:0050808) | 2.09369751 |
190 | response to pheromone (GO:0019236) | 2.08519434 |
191 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.07888823 |
192 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.07888823 |
193 | reflex (GO:0060004) | 2.07386508 |
194 | DNA double-strand break processing (GO:0000729) | 2.06809110 |
195 | head development (GO:0060322) | 2.06646555 |
196 | sympathetic nervous system development (GO:0048485) | 2.06577726 |
197 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.05709140 |
198 | neuron-neuron synaptic transmission (GO:0007270) | 2.05171017 |
199 | neuronal stem cell maintenance (GO:0097150) | 2.04850044 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.46417985 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.69012913 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.63889263 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.38987813 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.29797783 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.83227347 |
7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.64527582 |
8 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.51815119 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.48945629 |
10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.32761395 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.25353709 |
12 | * TAF15_26573619_Chip-Seq_HEK293_Human | 2.23717952 |
13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.15374430 |
14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.04846559 |
15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.93336992 |
16 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.92596786 |
17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89618465 |
18 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86336096 |
19 | EWS_26573619_Chip-Seq_HEK293_Human | 1.80915401 |
20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.78539472 |
21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.72800637 |
22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.72315379 |
23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.65330981 |
24 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.63127328 |
25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.62913143 |
26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62003316 |
27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.61574797 |
28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59766888 |
29 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.59642917 |
30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59258431 |
31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58909075 |
32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57589642 |
33 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56363107 |
34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55699255 |
35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.54951400 |
36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54550157 |
37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.54438118 |
38 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53926687 |
39 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.50726762 |
40 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.49911950 |
41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.47867192 |
42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.45652259 |
43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45297532 |
44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.44184091 |
45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.43804887 |
46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.42592626 |
47 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.41354034 |
48 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41122380 |
49 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41122380 |
50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.40211120 |
51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38500980 |
52 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38500980 |
53 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38329107 |
54 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37118567 |
55 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.36158164 |
56 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.36049139 |
57 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.35859701 |
58 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34246259 |
59 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.33091563 |
60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.32758101 |
61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32496264 |
62 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.31885038 |
63 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30225716 |
64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.29340129 |
65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27984942 |
66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27775283 |
67 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.26503987 |
68 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.25733618 |
69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.23881100 |
70 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.23809025 |
71 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.23480659 |
72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23163301 |
73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22650946 |
74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22184475 |
75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21518911 |
76 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.19953326 |
77 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.19046331 |
78 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.18683753 |
79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18085939 |
80 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17891859 |
81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17822685 |
82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17822685 |
83 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17590519 |
84 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17541340 |
85 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.17306583 |
86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16890832 |
87 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16833926 |
88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16712906 |
89 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16623237 |
90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16338858 |
91 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.16154406 |
92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15905467 |
93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15002512 |
94 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.14660130 |
95 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14243504 |
96 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14148991 |
97 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13945239 |
98 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13845938 |
99 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13812119 |
100 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13796401 |
101 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.13406765 |
102 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.13342780 |
103 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.12755955 |
104 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12517132 |
105 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.11905985 |
106 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11673421 |
107 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11449944 |
108 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.10568796 |
109 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09593631 |
110 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08628630 |
111 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08397893 |
112 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08389651 |
113 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08087578 |
114 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07820469 |
115 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.07319175 |
116 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07270967 |
117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07235389 |
118 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06556986 |
119 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.06336463 |
120 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06274641 |
121 | JUN_21703547_ChIP-Seq_K562_Human | 1.06194559 |
122 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06136652 |
123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05797524 |
124 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04479568 |
125 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.03557032 |
126 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03104147 |
127 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.02816987 |
128 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02554831 |
129 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02228326 |
130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02024890 |
131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01772649 |
132 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01557919 |
133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01425076 |
134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01425076 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.11608375 |
2 | MP0005360_urolithiasis | 6.18428127 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.61708849 |
4 | MP0005365_abnormal_bile_salt | 5.33809679 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.57138071 |
6 | MP0003252_abnormal_bile_duct | 3.46485458 |
7 | MP0004859_abnormal_synaptic_plasticity | 2.75881933 |
8 | MP0010329_abnormal_lipoprotein_level | 2.74209647 |
9 | MP0003122_maternal_imprinting | 2.59932460 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.51926071 |
11 | MP0003195_calcinosis | 2.46008988 |
12 | MP0009697_abnormal_copulation | 2.19628702 |
13 | MP0003880_abnormal_central_pattern | 2.14704357 |
14 | MP0005248_abnormal_Harderian_gland | 2.14652292 |
15 | MP0003868_abnormal_feces_composition | 2.05003094 |
16 | MP0005332_abnormal_amino_acid | 1.93553956 |
17 | MP0002638_abnormal_pupillary_reflex | 1.88742918 |
18 | MP0003121_genomic_imprinting | 1.87988204 |
19 | MP0002736_abnormal_nociception_after | 1.86401807 |
20 | MP0005083_abnormal_biliary_tract | 1.84937011 |
21 | MP0005670_abnormal_white_adipose | 1.84478277 |
22 | MP0006072_abnormal_retinal_apoptosis | 1.74756582 |
23 | MP0001666_abnormal_nutrient_absorption | 1.74057470 |
24 | MP0002735_abnormal_chemical_nociception | 1.73138575 |
25 | MP0001529_abnormal_vocalization | 1.69926549 |
26 | MP0005187_abnormal_penis_morphology | 1.69071210 |
27 | MP0004019_abnormal_vitamin_homeostasis | 1.67460257 |
28 | MP0002876_abnormal_thyroid_physiology | 1.66909849 |
29 | MP0002118_abnormal_lipid_homeostasis | 1.64837038 |
30 | MP0009745_abnormal_behavioral_response | 1.64684870 |
31 | MP0005451_abnormal_body_composition | 1.64411667 |
32 | MP0001968_abnormal_touch/_nociception | 1.61360472 |
33 | MP0004133_heterotaxia | 1.59061902 |
34 | MP0000631_abnormal_neuroendocrine_gland | 1.57655391 |
35 | MP0003635_abnormal_synaptic_transmissio | 1.51844131 |
36 | MP0003937_abnormal_limbs/digits/tail_de | 1.49603178 |
37 | MP0005646_abnormal_pituitary_gland | 1.48690971 |
38 | MP0001299_abnormal_eye_distance/ | 1.45461480 |
39 | MP0008789_abnormal_olfactory_epithelium | 1.45411959 |
40 | MP0002653_abnormal_ependyma_morphology | 1.45016855 |
41 | MP0004215_abnormal_myocardial_fiber | 1.44657363 |
42 | MP0002063_abnormal_learning/memory/cond | 1.42224038 |
43 | MP0002138_abnormal_hepatobiliary_system | 1.41765398 |
44 | MP0003787_abnormal_imprinting | 1.41534880 |
45 | MP0002572_abnormal_emotion/affect_behav | 1.40008651 |
46 | MP0009840_abnormal_foam_cell | 1.39490695 |
47 | MP0005253_abnormal_eye_physiology | 1.39065583 |
48 | MP0000609_abnormal_liver_physiology | 1.38665527 |
49 | MP0001984_abnormal_olfaction | 1.38549770 |
50 | MP0000049_abnormal_middle_ear | 1.33754403 |
51 | MP0002234_abnormal_pharynx_morphology | 1.33053443 |
52 | MP0002233_abnormal_nose_morphology | 1.32399985 |
53 | MP0001486_abnormal_startle_reflex | 1.29499388 |
54 | MP0001501_abnormal_sleep_pattern | 1.29454733 |
55 | MP0001440_abnormal_grooming_behavior | 1.29377209 |
56 | MP0002064_seizures | 1.29288852 |
57 | MP0000751_myopathy | 1.28821196 |
58 | MP0002938_white_spotting | 1.28667095 |
59 | MP0003890_abnormal_embryonic-extraembry | 1.25918147 |
60 | MP0005647_abnormal_sex_gland | 1.22932675 |
61 | MP0009780_abnormal_chondrocyte_physiolo | 1.21860069 |
62 | MP0005499_abnormal_olfactory_system | 1.21325033 |
63 | MP0005394_taste/olfaction_phenotype | 1.21325033 |
64 | MP0000566_synostosis | 1.20828278 |
65 | MP0000383_abnormal_hair_follicle | 1.20282884 |
66 | MP0005319_abnormal_enzyme/_coenzyme | 1.20192662 |
67 | MP0002697_abnormal_eye_size | 1.19377399 |
68 | MP0003755_abnormal_palate_morphology | 1.19329498 |
69 | MP0003191_abnormal_cellular_cholesterol | 1.14829974 |
70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13969582 |
71 | MP0004145_abnormal_muscle_electrophysio | 1.12693747 |
72 | MP0002882_abnormal_neuron_morphology | 1.09031236 |
73 | MP0009046_muscle_twitch | 1.08966943 |
74 | MP0001764_abnormal_homeostasis | 1.08065007 |
75 | MP0003119_abnormal_digestive_system | 1.07386645 |
76 | MP0000013_abnormal_adipose_tissue | 1.07372735 |
77 | MP0003137_abnormal_impulse_conducting | 1.06671377 |
78 | MP0003011_delayed_dark_adaptation | 1.06388393 |
79 | MP0002751_abnormal_autonomic_nervous | 1.05294247 |
80 | MP0002272_abnormal_nervous_system | 1.05180199 |
81 | MP0003283_abnormal_digestive_organ | 1.04551426 |
82 | MP0001293_anophthalmia | 1.04508321 |
83 | MP0004811_abnormal_neuron_physiology | 1.03880497 |
84 | MP0003385_abnormal_body_wall | 1.03358724 |
85 | MP0002752_abnormal_somatic_nervous | 1.02908914 |
86 | MP0000647_abnormal_sebaceous_gland | 1.02164348 |
87 | MP0009764_decreased_sensitivity_to | 1.02067668 |
88 | MP0010678_abnormal_skin_adnexa | 1.01510320 |
89 | MP0003690_abnormal_glial_cell | 1.00526824 |
90 | MP0002067_abnormal_sensory_capabilities | 0.98811210 |
91 | MP0004270_analgesia | 0.98622776 |
92 | MP0003938_abnormal_ear_development | 0.97884635 |
93 | MP0003861_abnormal_nervous_system | 0.96538860 |
94 | MP0006276_abnormal_autonomic_nervous | 0.96233787 |
95 | MP0002152_abnormal_brain_morphology | 0.95161978 |
96 | MP0004142_abnormal_muscle_tone | 0.92348380 |
97 | MP0004043_abnormal_pH_regulation | 0.92120686 |
98 | MP0005535_abnormal_body_temperature | 0.91091180 |
99 | MP0002822_catalepsy | 0.90844985 |
100 | MP0001661_extended_life_span | 0.90809140 |
101 | MP0003935_abnormal_craniofacial_develop | 0.90062791 |
102 | MP0005391_vision/eye_phenotype | 0.89317880 |
103 | MP0000778_abnormal_nervous_system | 0.88359046 |
104 | MP0001286_abnormal_eye_development | 0.87904211 |
105 | MP0003136_yellow_coat_color | 0.87821975 |
106 | MP0002909_abnormal_adrenal_gland | 0.87482869 |
107 | MP0005195_abnormal_posterior_eye | 0.87337543 |
108 | MP0008874_decreased_physiological_sensi | 0.87082950 |
109 | MP0005171_absent_coat_pigmentation | 0.86466560 |
110 | MP0004085_abnormal_heartbeat | 0.85046380 |
111 | MP0001970_abnormal_pain_threshold | 0.84681803 |
112 | MP0003942_abnormal_urinary_system | 0.83373369 |
113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82810444 |
114 | MP0002971_abnormal_brown_adipose | 0.82727801 |
115 | MP0009765_abnormal_xenobiotic_induced | 0.82387901 |
116 | MP0000462_abnormal_digestive_system | 0.82073451 |
117 | MP0010368_abnormal_lymphatic_system | 0.80754853 |
118 | MP0004130_abnormal_muscle_cell | 0.80672223 |
119 | MP0000579_abnormal_nail_morphology | 0.80484334 |
120 | MP0000604_amyloidosis | 0.79361796 |
121 | MP0005334_abnormal_fat_pad | 0.79332280 |
122 | MP0002733_abnormal_thermal_nociception | 0.79248409 |
123 | MP0005551_abnormal_eye_electrophysiolog | 0.78864290 |
124 | MP0005620_abnormal_muscle_contractility | 0.78738507 |
125 | MP0004381_abnormal_hair_follicle | 0.75720679 |
126 | MP0001502_abnormal_circadian_rhythm | 0.75567593 |
127 | MP0008877_abnormal_DNA_methylation | 0.73032978 |
128 | MP0006292_abnormal_olfactory_placode | 0.72714238 |
129 | MP0002557_abnormal_social/conspecific_i | 0.71320838 |
130 | MP0000569_abnormal_digit_pigmentation | 0.68987327 |
131 | MP0009763_increased_sensitivity_to | 0.68486303 |
132 | MP0002078_abnormal_glucose_homeostasis | 0.65162334 |
133 | MP0002184_abnormal_innervation | 0.64302254 |
134 | MP0000955_abnormal_spinal_cord | 0.63304088 |
135 | MP0004885_abnormal_endolymph | 0.63091183 |
136 | MP0002254_reproductive_system_inflammat | 0.63042583 |
137 | MP0005448_abnormal_energy_balance | 0.62923271 |
138 | MP0001188_hyperpigmentation | 0.61993075 |
139 | MP0001177_atelectasis | 0.61744820 |
140 | MP0003879_abnormal_hair_cell | 0.61076062 |
141 | MP0002837_dystrophic_cardiac_calcinosis | 0.60387419 |
142 | MP0003329_amyloid_beta_deposits | 0.59251198 |
143 | MP0002734_abnormal_mechanical_nocicepti | 0.58605513 |
144 | MP0005645_abnormal_hypothalamus_physiol | 0.57462386 |
145 | MP0004924_abnormal_behavior | 0.56787805 |
146 | MP0005386_behavior/neurological_phenoty | 0.56787805 |
147 | MP0009642_abnormal_blood_homeostasis | 0.56756553 |
148 | MP0002102_abnormal_ear_morphology | 0.53693835 |
149 | MP0003633_abnormal_nervous_system | 0.53009488 |
150 | MP0002069_abnormal_eating/drinking_beha | 0.51242897 |
151 | MP0005636_abnormal_mineral_homeostasis | 0.47887146 |
152 | MP0002066_abnormal_motor_capabilities/c | 0.47611168 |
153 | MP0001963_abnormal_hearing_physiology | 0.47122256 |
154 | MP0000026_abnormal_inner_ear | 0.46730056 |
155 | MP0000427_abnormal_hair_cycle | 0.46598107 |
156 | MP0003631_nervous_system_phenotype | 0.46116610 |
157 | MP0005423_abnormal_somatic_nervous | 0.45701175 |
158 | MP0005595_abnormal_vascular_smooth | 0.45512724 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 6.39707002 |
2 | Deep venous thrombosis (HP:0002625) | 6.32075974 |
3 | Prolonged partial thromboplastin time (HP:0003645) | 6.28033237 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.97763708 |
5 | Hypobetalipoproteinemia (HP:0003563) | 5.73546618 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.11406886 |
7 | Xanthomatosis (HP:0000991) | 4.92275279 |
8 | Hyperlipoproteinemia (HP:0010980) | 4.74445476 |
9 | Complement deficiency (HP:0004431) | 4.58582990 |
10 | Epidermoid cyst (HP:0200040) | 4.45906032 |
11 | Joint hemorrhage (HP:0005261) | 4.45675458 |
12 | Abnormality of methionine metabolism (HP:0010901) | 4.37763632 |
13 | Hypolipoproteinemia (HP:0010981) | 4.21210709 |
14 | Conjugated hyperbilirubinemia (HP:0002908) | 4.14856516 |
15 | Focal motor seizures (HP:0011153) | 3.96127528 |
16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.89498961 |
17 | Hyperventilation (HP:0002883) | 3.88260967 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.83599787 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.70108919 |
20 | Hyperammonemia (HP:0001987) | 3.67238142 |
21 | Hypoalphalipoproteinemia (HP:0003233) | 3.63181725 |
22 | Hyperglycinemia (HP:0002154) | 3.62100189 |
23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.58918513 |
24 | Fat malabsorption (HP:0002630) | 3.43408495 |
25 | Ketosis (HP:0001946) | 3.39870596 |
26 | Fair hair (HP:0002286) | 3.35529810 |
27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.27647457 |
28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.18550738 |
29 | Type II lissencephaly (HP:0007260) | 3.15864823 |
30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.15037276 |
31 | Abnormality of complement system (HP:0005339) | 3.07583608 |
32 | Spontaneous abortion (HP:0005268) | 3.03749978 |
33 | Abnormality of serum amino acid levels (HP:0003112) | 3.03743421 |
34 | Gait imbalance (HP:0002141) | 2.95493662 |
35 | Medial flaring of the eyebrow (HP:0010747) | 2.95246302 |
36 | Hypercholesterolemia (HP:0003124) | 2.93128184 |
37 | Congenital primary aphakia (HP:0007707) | 2.80265083 |
38 | Abnormality of glycine metabolism (HP:0010895) | 2.79621638 |
39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.79621638 |
40 | Febrile seizures (HP:0002373) | 2.79229436 |
41 | Pancreatic cysts (HP:0001737) | 2.77740717 |
42 | Hypochromic microcytic anemia (HP:0004840) | 2.74570927 |
43 | Atonic seizures (HP:0010819) | 2.72068449 |
44 | Pancreatic fibrosis (HP:0100732) | 2.70811003 |
45 | Retinal dysplasia (HP:0007973) | 2.66669258 |
46 | Abnormality of the labia minora (HP:0012880) | 2.66548433 |
47 | Delayed CNS myelination (HP:0002188) | 2.61787060 |
48 | Genital tract atresia (HP:0001827) | 2.61361262 |
49 | Nephrogenic diabetes insipidus (HP:0009806) | 2.61024531 |
50 | Cerebellar dysplasia (HP:0007033) | 2.59570850 |
51 | Hyperglycinuria (HP:0003108) | 2.57329138 |
52 | Blue irides (HP:0000635) | 2.56097137 |
53 | Vaginal atresia (HP:0000148) | 2.54598406 |
54 | Polyphagia (HP:0002591) | 2.54367434 |
55 | True hermaphroditism (HP:0010459) | 2.53840230 |
56 | Hypoglycemic coma (HP:0001325) | 2.53574007 |
57 | Steatorrhea (HP:0002570) | 2.52117477 |
58 | Metabolic acidosis (HP:0001942) | 2.51885392 |
59 | Chronic hepatic failure (HP:0100626) | 2.51683438 |
60 | Ketoacidosis (HP:0001993) | 2.50341957 |
61 | Acanthocytosis (HP:0001927) | 2.50299933 |
62 | Nephronophthisis (HP:0000090) | 2.46608563 |
63 | Skin nodule (HP:0200036) | 2.44584245 |
64 | Generalized hypopigmentation of hair (HP:0011358) | 2.42812320 |
65 | Status epilepticus (HP:0002133) | 2.42782917 |
66 | Vascular calcification (HP:0004934) | 2.39660631 |
67 | Cutaneous finger syndactyly (HP:0010554) | 2.38627468 |
68 | Confusion (HP:0001289) | 2.34660478 |
69 | Lissencephaly (HP:0001339) | 2.34171941 |
70 | Methylmalonic acidemia (HP:0002912) | 2.33933776 |
71 | Hyperbilirubinemia (HP:0002904) | 2.31044524 |
72 | Opisthotonus (HP:0002179) | 2.27755245 |
73 | Potter facies (HP:0002009) | 2.25585033 |
74 | Facial shape deformation (HP:0011334) | 2.25585033 |
75 | Epileptic encephalopathy (HP:0200134) | 2.19966734 |
76 | Papillary thyroid carcinoma (HP:0002895) | 2.19220265 |
77 | Hypoglycemic seizures (HP:0002173) | 2.19214739 |
78 | Abnormality of nucleobase metabolism (HP:0010932) | 2.18292129 |
79 | Myocardial infarction (HP:0001658) | 2.18127193 |
80 | Broad-based gait (HP:0002136) | 2.17626359 |
81 | Optic nerve hypoplasia (HP:0000609) | 2.16073542 |
82 | Hepatoblastoma (HP:0002884) | 2.15547218 |
83 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.14805250 |
84 | Abnormality of the renal medulla (HP:0100957) | 2.14440647 |
85 | Enlarged kidneys (HP:0000105) | 2.14076619 |
86 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.12545482 |
87 | Postaxial hand polydactyly (HP:0001162) | 2.12316003 |
88 | Hepatocellular carcinoma (HP:0001402) | 2.11814389 |
89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.11316328 |
90 | Septo-optic dysplasia (HP:0100842) | 2.09211907 |
91 | Renal cortical cysts (HP:0000803) | 2.07046245 |
92 | Cardiovascular calcification (HP:0011915) | 2.05619537 |
93 | Colon cancer (HP:0003003) | 2.04519086 |
94 | Dialeptic seizures (HP:0011146) | 2.04207053 |
95 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.03885829 |
96 | Gingival bleeding (HP:0000225) | 2.03030182 |
97 | Molar tooth sign on MRI (HP:0002419) | 2.02999405 |
98 | Abnormality of midbrain morphology (HP:0002418) | 2.02999405 |
99 | Progressive cerebellar ataxia (HP:0002073) | 2.00732561 |
100 | Abnormality of vitamin metabolism (HP:0100508) | 2.00227342 |
101 | Abnormality of the ischium (HP:0003174) | 1.99612200 |
102 | Postaxial foot polydactyly (HP:0001830) | 1.99597558 |
103 | Cutaneous syndactyly (HP:0012725) | 1.98785676 |
104 | Preaxial foot polydactyly (HP:0001841) | 1.95571097 |
105 | Sensorimotor neuropathy (HP:0007141) | 1.94917257 |
106 | Absence seizures (HP:0002121) | 1.94630700 |
107 | Short tibia (HP:0005736) | 1.94630631 |
108 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.94197622 |
109 | Poor coordination (HP:0002370) | 1.88053749 |
110 | Bile duct proliferation (HP:0001408) | 1.88040857 |
111 | Abnormal biliary tract physiology (HP:0012439) | 1.88040857 |
112 | Occipital encephalocele (HP:0002085) | 1.87282506 |
113 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.86513576 |
114 | Hypophosphatemic rickets (HP:0004912) | 1.86056562 |
115 | Generalized tonic-clonic seizures (HP:0002069) | 1.84225025 |
116 | Menorrhagia (HP:0000132) | 1.82595701 |
117 | Symptomatic seizures (HP:0011145) | 1.82558026 |
118 | Broad foot (HP:0001769) | 1.82445985 |
119 | Dicarboxylic aciduria (HP:0003215) | 1.82417169 |
120 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.82417169 |
121 | Short foot (HP:0001773) | 1.82405711 |
122 | Neonatal onset (HP:0003623) | 1.81828100 |
123 | Pachygyria (HP:0001302) | 1.81363245 |
124 | Cystic liver disease (HP:0006706) | 1.80298882 |
125 | Micropenis (HP:0000054) | 1.79446593 |
126 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.79341910 |
127 | Tubulointerstitial nephritis (HP:0001970) | 1.79285748 |
128 | Mitral stenosis (HP:0001718) | 1.79191166 |
129 | Lethargy (HP:0001254) | 1.78422275 |
130 | Epileptiform EEG discharges (HP:0011182) | 1.78211628 |
131 | Hemiparesis (HP:0001269) | 1.77551926 |
132 | Toxemia of pregnancy (HP:0100603) | 1.77171208 |
133 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.77008701 |
134 | Supernumerary spleens (HP:0009799) | 1.76602778 |
135 | Focal seizures (HP:0007359) | 1.76217546 |
136 | Limb dystonia (HP:0002451) | 1.76137333 |
137 | Specific learning disability (HP:0001328) | 1.75316403 |
138 | Oligodactyly (hands) (HP:0001180) | 1.74621393 |
139 | Systemic lupus erythematosus (HP:0002725) | 1.74417081 |
140 | Narrow forehead (HP:0000341) | 1.74333425 |
141 | Cortical dysplasia (HP:0002539) | 1.73846253 |
142 | Drooling (HP:0002307) | 1.72709986 |
143 | Excessive salivation (HP:0003781) | 1.72709986 |
144 | Abnormal gallbladder morphology (HP:0012437) | 1.71003107 |
145 | Tubular atrophy (HP:0000092) | 1.70952797 |
146 | Synostosis involving the elbow (HP:0003938) | 1.70589901 |
147 | Humeroradial synostosis (HP:0003041) | 1.70589901 |
148 | EEG with generalized epileptiform discharges (HP:0011198) | 1.70476628 |
149 | Hypsarrhythmia (HP:0002521) | 1.70077081 |
150 | Abnormality of purine metabolism (HP:0004352) | 1.69919556 |
151 | Intestinal atresia (HP:0011100) | 1.69752150 |
152 | Neonatal respiratory distress (HP:0002643) | 1.69509838 |
153 | Renal dysplasia (HP:0000110) | 1.68630476 |
154 | Renal hypoplasia (HP:0000089) | 1.67381815 |
155 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.66948416 |
156 | Abnormality of the renal cortex (HP:0011035) | 1.66373253 |
157 | Volvulus (HP:0002580) | 1.66195564 |
158 | Urinary urgency (HP:0000012) | 1.65853738 |
159 | Fibular aplasia (HP:0002990) | 1.65692930 |
160 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.65514432 |
161 | Absent/shortened dynein arms (HP:0200106) | 1.65514432 |
162 | Absent speech (HP:0001344) | 1.63799834 |
163 | Labial hypoplasia (HP:0000066) | 1.63073784 |
164 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.62763631 |
165 | Abnormality of homocysteine metabolism (HP:0010919) | 1.62404949 |
166 | Homocystinuria (HP:0002156) | 1.62404949 |
167 | Absent eyebrow (HP:0002223) | 1.62404043 |
168 | Sclerocornea (HP:0000647) | 1.62176577 |
169 | Amyloidosis (HP:0011034) | 1.61070477 |
170 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.60722484 |
171 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.60722484 |
172 | Protruding tongue (HP:0010808) | 1.60427153 |
173 | Inability to walk (HP:0002540) | 1.60136779 |
174 | Abnormality of the calf musculature (HP:0001430) | 1.59903390 |
175 | Tented upper lip vermilion (HP:0010804) | 1.58406889 |
176 | Abnormality of the astrocytes (HP:0100707) | 1.58188825 |
177 | Astrocytoma (HP:0009592) | 1.58188825 |
178 | Pheochromocytoma (HP:0002666) | 1.57618257 |
179 | Glioma (HP:0009733) | 1.56630472 |
180 | Congenital hepatic fibrosis (HP:0002612) | 1.56047253 |
181 | Esotropia (HP:0000565) | 1.55943309 |
182 | Keratoconus (HP:0000563) | 1.55876641 |
183 | Increased corneal curvature (HP:0100692) | 1.55876641 |
184 | Bifid tongue (HP:0010297) | 1.55856380 |
185 | Shoulder girdle muscle weakness (HP:0003547) | 1.54977194 |
186 | Hypoplastic ischia (HP:0003175) | 1.54803515 |
187 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.54782894 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.29027934 |
2 | NTRK3 | 3.94743911 |
3 | INSRR | 3.12886946 |
4 | CASK | 3.07745163 |
5 | WNK3 | 2.81834571 |
6 | FRK | 2.57320511 |
7 | MAP4K2 | 2.40647265 |
8 | ERBB4 | 2.34902739 |
9 | MAP2K7 | 2.33164962 |
10 | ERBB3 | 2.31720436 |
11 | BCR | 2.20406360 |
12 | SIK1 | 2.20063671 |
13 | MAP3K4 | 2.18814485 |
14 | MAP2K4 | 2.10996788 |
15 | TNIK | 1.95451277 |
16 | STK16 | 1.77719058 |
17 | PRPF4B | 1.72406584 |
18 | NTRK2 | 1.64143830 |
19 | LATS1 | 1.63949877 |
20 | PNCK | 1.63676849 |
21 | TAOK3 | 1.63052910 |
22 | SGK2 | 1.53639713 |
23 | MKNK2 | 1.49606053 |
24 | BMPR2 | 1.38148577 |
25 | DAPK2 | 1.38099179 |
26 | CSNK1G1 | 1.36216984 |
27 | MARK1 | 1.34035667 |
28 | MINK1 | 1.32536275 |
29 | BCKDK | 1.31561593 |
30 | MUSK | 1.30325294 |
31 | PINK1 | 1.30010427 |
32 | PRKAA2 | 1.29548542 |
33 | MAPK13 | 1.29296210 |
34 | MKNK1 | 1.26301204 |
35 | FGFR4 | 1.22408275 |
36 | NUAK1 | 1.21348042 |
37 | MAP3K7 | 1.18305939 |
38 | AKT3 | 1.18077163 |
39 | PKN1 | 1.17889319 |
40 | TAOK2 | 1.17476030 |
41 | CSNK1G3 | 1.17150909 |
42 | MAP3K14 | 1.14838987 |
43 | DYRK2 | 1.14344019 |
44 | MAP3K13 | 1.13625517 |
45 | DYRK3 | 1.13551242 |
46 | BMPR1B | 1.12417321 |
47 | SGK223 | 1.11347933 |
48 | SGK494 | 1.11347933 |
49 | SRPK1 | 1.11289922 |
50 | CAMKK2 | 1.07453265 |
51 | SGK3 | 1.06598977 |
52 | TXK | 1.05611041 |
53 | PRKCG | 1.05247705 |
54 | CAMK2A | 1.04961824 |
55 | SIK3 | 1.04792527 |
56 | CAMK1G | 1.01319113 |
57 | BRSK2 | 1.00394684 |
58 | BRD4 | 0.98165141 |
59 | PLK2 | 0.98037316 |
60 | PRKD3 | 0.98018161 |
61 | SGK1 | 0.97352640 |
62 | MAP3K6 | 0.95203054 |
63 | FGFR2 | 0.95103316 |
64 | CAMK1D | 0.94062967 |
65 | CSNK1G2 | 0.93333889 |
66 | CAMK2B | 0.93000471 |
67 | MARK2 | 0.90792620 |
68 | EPHA3 | 0.90080385 |
69 | OBSCN | 0.88769833 |
70 | TRIM28 | 0.87732286 |
71 | PHKG2 | 0.87276832 |
72 | PHKG1 | 0.87276832 |
73 | MAPK7 | 0.87020415 |
74 | MAPK11 | 0.86706829 |
75 | CCNB1 | 0.86701294 |
76 | SIK2 | 0.86436293 |
77 | IRAK1 | 0.86152247 |
78 | PIK3CG | 0.85750339 |
79 | CDK19 | 0.85365966 |
80 | PRKCQ | 0.83817721 |
81 | WEE1 | 0.81094008 |
82 | NEK1 | 0.80584703 |
83 | CDK3 | 0.77913325 |
84 | CAMK2G | 0.77491690 |
85 | EIF2AK3 | 0.76878137 |
86 | EIF2AK1 | 0.74558449 |
87 | EIF2AK2 | 0.74504157 |
88 | PRKCE | 0.74303303 |
89 | KSR1 | 0.74263443 |
90 | PRKAA1 | 0.74154167 |
91 | UHMK1 | 0.72169806 |
92 | EPHB2 | 0.72136800 |
93 | MAPK12 | 0.71259576 |
94 | ACVR1B | 0.70604872 |
95 | PRKG1 | 0.65915850 |
96 | JAK1 | 0.64399834 |
97 | NEK6 | 0.64211482 |
98 | PRKCZ | 0.63895177 |
99 | FES | 0.63645379 |
100 | CAMKK1 | 0.63555463 |
101 | ZAK | 0.61989725 |
102 | YES1 | 0.61871126 |
103 | STK39 | 0.61170700 |
104 | MAP3K5 | 0.61033632 |
105 | GRK1 | 0.60789124 |
106 | RPS6KA4 | 0.60655116 |
107 | ADRBK2 | 0.60467311 |
108 | MET | 0.58283149 |
109 | CDK5 | 0.57854206 |
110 | PLK3 | 0.57808449 |
111 | PLK4 | 0.57110189 |
112 | FER | 0.56674866 |
113 | STK3 | 0.54685987 |
114 | CAMK1 | 0.52956488 |
115 | PIK3CA | 0.52308211 |
116 | ABL2 | 0.51803460 |
117 | IGF1R | 0.51744094 |
118 | STK38L | 0.51025952 |
119 | CAMK4 | 0.50974982 |
120 | CAMK2D | 0.50872684 |
121 | MAPK15 | 0.50371195 |
122 | LATS2 | 0.49823006 |
123 | PRKACG | 0.48751986 |
124 | PRKACB | 0.47514128 |
125 | PAK6 | 0.46797060 |
126 | NEK9 | 0.46472494 |
127 | OXSR1 | 0.46078169 |
128 | STK38 | 0.45973129 |
129 | RPS6KA3 | 0.44985364 |
130 | PRKCA | 0.44611822 |
131 | PRKCB | 0.44223487 |
132 | MAP2K6 | 0.43427875 |
133 | PLK1 | 0.43398729 |
134 | PRKACA | 0.43340035 |
135 | ERBB2 | 0.41659525 |
136 | DYRK1A | 0.40768108 |
137 | CSNK1A1 | 0.40524289 |
138 | VRK1 | 0.39059832 |
139 | GRK7 | 0.38493100 |
140 | STK11 | 0.38375334 |
141 | CSNK1A1L | 0.38149218 |
142 | PAK3 | 0.38065069 |
143 | PTK2B | 0.37458944 |
144 | ATM | 0.36811809 |
145 | MAP3K9 | 0.36092208 |
146 | CDK18 | 0.35724668 |
147 | CDC7 | 0.34022958 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.48840527 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18186382 |
3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.17074113 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96558997 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93970218 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62045523 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50912937 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45237505 |
9 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.38033935 |
10 | Protein export_Homo sapiens_hsa03060 | 2.24699118 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07649500 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06534459 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02039416 |
14 | Retinol metabolism_Homo sapiens_hsa00830 | 1.95965748 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95755464 |
16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.94434440 |
17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93644746 |
18 | Peroxisome_Homo sapiens_hsa04146 | 1.88747990 |
19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.83659276 |
20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.81357109 |
21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78984050 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75979099 |
23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.75341355 |
24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71283818 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65540915 |
26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64487362 |
27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.62470637 |
28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.62004000 |
29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60768313 |
30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59315121 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.57532294 |
32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55024518 |
33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54533936 |
34 | Bile secretion_Homo sapiens_hsa04976 | 1.54058930 |
35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.48210269 |
36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.46532081 |
37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40297925 |
38 | Phototransduction_Homo sapiens_hsa04744 | 1.40162546 |
39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36600545 |
40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.32103202 |
41 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28944272 |
42 | ABC transporters_Homo sapiens_hsa02010 | 1.28686401 |
43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28252582 |
44 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.27327753 |
45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24735591 |
46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.23761478 |
47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21648713 |
48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18615066 |
49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.18310262 |
50 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.18142298 |
51 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.15899712 |
52 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.14720267 |
53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14193253 |
54 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.11872253 |
55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10539462 |
56 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.07512225 |
57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07449316 |
58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.06928481 |
59 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.06849490 |
60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05785253 |
61 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.04973245 |
62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.01467449 |
63 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99647983 |
64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97224768 |
65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.96698004 |
66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93631904 |
67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92484727 |
68 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.92277411 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90031864 |
70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.89702798 |
71 | Gap junction_Homo sapiens_hsa04540 | 0.89522827 |
72 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.88594546 |
73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87692285 |
74 | Lysine degradation_Homo sapiens_hsa00310 | 0.87669851 |
75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80428558 |
76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78690895 |
77 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.78510066 |
78 | GABAergic synapse_Homo sapiens_hsa04727 | 0.77979931 |
79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76480068 |
80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76158927 |
81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74095620 |
82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73173892 |
83 | Melanogenesis_Homo sapiens_hsa04916 | 0.73024589 |
84 | Tight junction_Homo sapiens_hsa04530 | 0.69501843 |
85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67308933 |
86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66866859 |
87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65735478 |
88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.64419466 |
89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64192880 |
90 | Morphine addiction_Homo sapiens_hsa05032 | 0.62725584 |
91 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62688375 |
92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58910987 |
93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58807165 |
94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58318133 |
95 | Adherens junction_Homo sapiens_hsa04520 | 0.56769325 |
96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56422666 |
97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56059761 |
98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54987738 |
99 | Homologous recombination_Homo sapiens_hsa03440 | 0.54908383 |
100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53858531 |
101 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53178294 |
102 | Alcoholism_Homo sapiens_hsa05034 | 0.52642131 |
103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50469380 |
104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.48360550 |
105 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.47873044 |
106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46677299 |
107 | Taste transduction_Homo sapiens_hsa04742 | 0.46292523 |
108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45742877 |
109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45418541 |
110 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41850062 |
111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41814351 |
112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41664619 |
113 | RNA degradation_Homo sapiens_hsa03018 | 0.39993191 |
114 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39908287 |
115 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36962760 |
116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36890931 |
117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36418003 |
118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34606696 |
119 | Prion diseases_Homo sapiens_hsa05020 | 0.33092494 |
120 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32064954 |
121 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31800650 |
122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31785054 |
123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30708000 |
124 | Cocaine addiction_Homo sapiens_hsa05030 | 0.29865379 |
125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27624857 |
126 | Insulin secretion_Homo sapiens_hsa04911 | 0.27483329 |
127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25831882 |
128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25608403 |
129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25000241 |
130 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.22031601 |
131 | Long-term depression_Homo sapiens_hsa04730 | 0.21176700 |
132 | Salivary secretion_Homo sapiens_hsa04970 | 0.21116942 |
133 | Axon guidance_Homo sapiens_hsa04360 | 0.18987020 |
134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17809209 |
135 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.17685119 |
136 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.15728175 |
137 | Renin secretion_Homo sapiens_hsa04924 | 0.14210291 |
138 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12755458 |
139 | Insulin resistance_Homo sapiens_hsa04931 | 0.11862577 |
140 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10702961 |
141 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.10523818 |
142 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10000379 |
143 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09317836 |
144 | Sulfur relay system_Homo sapiens_hsa04122 | 0.08627588 |
145 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.08407191 |